Both in Pharmaceuticals
Spyre Therapeutics vs Ionis Pharmaceuticals
Over the past year SYRE returned +417.8% and IONS returned −28.5%; their daily moves had a correlation of 0.21.
SYRE +417.8% IONS −28.5%Growth of $1, one year, split-adjusted
| Metric | SYRE | IONS |
|---|---|---|
| Price | $84.72 | $45.89 |
| Market cap | $7.47B | $7.63B |
| Today | −1.25% | +0.70% |
| 1 month | −6.2% | −24.8% |
| 6 months | +86.5% | −36.7% |
| Year to date | +158.6% | −42.0% |
| 1 year | +421.7% | −28.4% |
| Revenue growth (YoY) | — | −40.7% |
| Gross margin | — | 99.0% |
| Net margin | — | −42.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.7× |
| Net cash | $1.15B | $732.0M |
| Dividend yield | — | — |
| Volatility (60d) | 55.1% | 71.8% |
| Short % of float | 15.1% | 12.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).